These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27404014)

  • 1. Contacting dropouts from type 2 diabetes care in public primary health care: description of the patient population.
    Kauppila T; Laine MK; Honkasalo M; Raina M; Eriksson JG
    Scand J Prim Health Care; 2016 Sep; 34(3):267-73. PubMed ID: 27404014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between number of contacts between previous dropouts with type 2 diabetes and health care professionals on glycaemic control: A cohort study in public primary health care.
    Kauppila T; Eriksson JG; Honkasalo M; Raina M; Laine MK
    Prim Care Diabetes; 2019 Oct; 13(5):468-473. PubMed ID: 30928432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes.
    Lavikainen P; Aarnio E; Jalkanen K; Tirkkonen H; Rautiainen P; Laatikainen T; Martikainen J
    BMC Health Serv Res; 2020 Nov; 20(1):1095. PubMed ID: 33246453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal follow-up study of a type 2 diabetes "lost to follow-up" cohort - positive effect on glycaemic control after changes in medication.
    Kauppila T; Laine MK; Honkasalo M; Raina M; Eriksson JG
    Int J Circumpolar Health; 2020 Jan; 79(1):1773127. PubMed ID: 32498629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
    Ali MK; Chwastiak L; Poongothai S; Emmert-Fees KMF; Patel SA; Anjana RM; Sagar R; Shankar R; Sridhar GR; Kosuri M; Sosale AR; Sosale B; Rao D; Tandon N; Narayan KMV; Mohan V;
    JAMA; 2020 Aug; 324(7):651-662. PubMed ID: 32809002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of intervention on metabolic outcomes among dropouts with type 2 diabetes.
    Laine MK; Kauppila T; Honkasalo M; Raina M; Eriksson JG
    Adv Med Sci; 2018 Mar; 63(1):5-8. PubMed ID: 28763676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
    Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
    Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis.
    Whyte MB; Hinton W; McGovern A; van Vlymen J; Ferreira F; Calderara S; Mount J; Munro N; de Lusignan S
    PLoS Med; 2019 Oct; 16(10):e1002942. PubMed ID: 31589609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial.
    Rodbard HW; Lingvay I; Reed J; de la Rosa R; Rose L; Sugimoto D; Araki E; Chu PL; Wijayasinghe N; Norwood P
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2291-2301. PubMed ID: 29688502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision Medicine to Redefine Insulin Secretion and Monogenic Diabetes-Randomized Controlled Trial (PRISM-RCT) in Chinese patients with young-onset diabetes: design, methods and baseline characteristics.
    O CK; Fan YN; Fan B; Lim C; Lau ESH; Tsoi STF; Wan R; Lai WY; Poon EW; Ho J; Ho CCY; Fung C; Lee EK; Wong SY; Wang M; Ozaki R; Cheung E; Ma RCW; Chow E; Kong APS; Luk A; Chan JCN
    BMJ Open Diabetes Res Care; 2024 Jun; 12(3):. PubMed ID: 38901858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of a Personalized Care Plan for Patients With Type 2 Diabetes Is Associated With Improvements in Clinical Outcomes: An Observational Real-World Study.
    Vuohijoki A; Mikkola I; Jokelainen J; Keinänen-Kiukaanniemi S; Winell K; Frittitta L; Timonen M; Hagnäs M
    J Prim Care Community Health; 2020; 11():2150132720921700. PubMed ID: 32450742
    [No Abstract]   [Full Text] [Related]  

  • 12. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inadequate Glycaemic Control and Therapeutic Management of Adults over 65 Years Old with Type 2 Diabetes Mellitus in Spain.
    Formiga F; Franch-Nadal J; Rodriguez L; Ávila L; Fuster E
    J Nutr Health Aging; 2017; 21(10):1365-1370. PubMed ID: 29188902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in Denmark.
    Safai N; Carstensen B; Vestergaard H; Ridderstråle M
    BMJ Open; 2018 Mar; 8(3):e019214. PubMed ID: 29550776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences and correlates of poor glycaemic control in type 2 diabetes: a cross-sectional study in Brazil and Venezuela.
    G Duarte F; da Silva Moreira S; Almeida MDCC; de Souza Teles CA; Andrade CS; Reingold AL; Moreira ED
    BMJ Open; 2019 Mar; 9(3):e023401. PubMed ID: 30842107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality in Individuals Aged 80 and Older with Type 2 Diabetes Mellitus in Relation to Glycosylated Hemoglobin, Blood Pressure, and Total Cholesterol.
    Hamada S; Gulliford MC
    J Am Geriatr Soc; 2016 Jul; 64(7):1425-31. PubMed ID: 27295278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry.
    Nambam B; Silverstein J; Cheng P; Ruedy KJ; Beck RW; Paul Wadwa R; Klingensmith G; Willi SM; Wood JR; Bacha F; Thomas IH; Tamborlane WV;
    Pediatr Diabetes; 2017 May; 18(3):222-229. PubMed ID: 26970319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative.
    Vashisht R; Jung K; Schuler A; Banda JM; Park RW; Jin S; Li L; Dudley JT; Johnson KW; Shervey MM; Xu H; Wu Y; Natrajan K; Hripcsak G; Jin P; Van Zandt M; Reckard A; Reich CG; Weaver J; Schuemie MJ; Ryan PB; Callahan A; Shah NH
    JAMA Netw Open; 2018 Aug; 1(4):e181755. PubMed ID: 30646124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achievement of therapeutic targets in Mexican patients with diabetes mellitus.
    Lavalle-González FJ; Chiquete E; de la Luz J; Ochoa-Guzmán A; Sánchez-Orozco LV; Godínez-Gutiérrez SA;
    Endocrinol Nutr; 2012 Dec; 59(10):591-8. PubMed ID: 23137765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.